Birth asphyxia is a leading case of neonatal morbidity and mortality especially in developing countries. Hypoxic-ischemic encephalopathy (HIE) attributed to asphyxia can be ameliorated with several remedies, although full recovery is currently not feasible. The aim of this trial on infants with HIE who are receiving melatonin therapy, is to assess the added effect of magnesium sulfate (MgSO4) on the expression of S100-B, a marker of brain injury.
METHODS:
This study is a randomized controlled trial on neonates with moderate HIE (Sarnat grade II). Infants were randomized into 2 groups; group1 who received MgSO4 and melatonin; and group 2 who received melatonin only. Serum concentrations of S100-B were measured at baseline, and at days 2 and 6 of therapy.
RESULTS:
The study included 60 neonates of them 30 infants in group 1 and 30 infants in group 2. S100-B did not differ between groups 1 and 2 at enrollment (median = 13.5 vs 13.2, p = 0.381). However, group 1 had lower concentrations of S100-B at 2 days (median = 8 vs 12, p = 0.001) and at 6 days (median = 3 vs 10.5, p < 0.001), respectively. Compared to baseline, S100-B decreased in in group 2 at day 6 (13.2 vs 10.5, p = 0.011) but did not decrease at day 2 (13.2 vs 12, p = 0.478).
CONCLUSIONS:
MgSO4 may have an added effect for the reduction in brain injury in infants with HIE who are receiving melatonin.
ShettyJ. Neonatal seizures in hypoxic-ischaemic encephalopathy-risks and benefits of anticonvulsant therapy. Dev Med Child Neurol. 2015;57:40–3.
2.
DoychevaD, ShihG, ChenH, ApplegateR, ZhangJH, TangJ. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment. Transl Stroke Res. 2013;4(2):171–8.
3.
WayockCP, MeseroleRL, SariaS, JenningsJM, HuismanTA, NorthingtonFJ, et al. Perinatal risk factors for severe injury in neonates treated with whole-body hypothermia for encephalopathy. Am J Obstet Gynecol. 2014;211(1):41–8.
4.
Douglas-EscobarM, WeissMD. Hypoxic-ischemic encephalopathy: A review for the clinician. JAMA Pediatr. 2015;169(4):397–403.
5.
GalinskyR, BennetL, GroenendaalF, LearCA, TanS, van BelF, et al. Magnesium is not consistently neuroprotective for perinatal hypoxia-ischemia in term-equivalent models in preclinical studies: A systematic review. Dev Neurosci. 2014;36(2):73–82.
6.
TaginM, ShahPS, LeeKS. Magnesium for newborns with hypoxic-ischemic encephalopathy: A systematic review and meta-analysis. J Perinatol. 2013;33(9):663–9.
7.
ShiLH, ZhouY, GuoMF, LiuJS, LiCX, WangGF, et al. Serum levels of S-100β correlate with the clinical status and severity of hypoxic-ischemic encephalopathy in neonates. Genet Mol Res. 2015;14(4):14760–71.
8.
BeharierO, KahnJ, ShustermanE, SheinerE. S100B - a potential biomarker for early detection of neonatal brain damage following asphyxia. J Matern Fetal Neonatal Med. 2012;25(9):1523–8.
9.
YildizEP, EkiciB, TatliB. Neonatal hypoxic ischemic encephalopathy: An update on disease pathogenesis and treatment. Expert Rev Neurother. 2017;17(5):449–59.
10.
BellSG. Hypoxic-ischemic encephalopathy and serum magnesium monitoring and maintenance. Neonatal Netw. 2016;35(3):159–63.
11.
SarnatHB, SarnatM. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33(10):696–705.
12.
IchibaH, TamaiH, NegishiH, UedaT, KimTJ, SumidaY, et al. Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatr Int. 2002;44(5):505–9.
13.
AlyH, ElmahdyH, El-DibM, RowishaM, AwnyM, El-GoharyT, et al. Melatonin use for neuroprotection in perinatal asphyxia: A randomized controlled pilot study. J Perinatol. 2015;35(3):186–91.
BattonB, LiL, NewmanNS, DasA, WatterbergKL, YoderBA, et al. Evolving blood pressure dynamics for extremely preterm infants. J Perinatol. 2014;34(4):301–5.
16.
NorthingtonFJ, Chavez-ValdezR, MartinLJ. Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol. 2011;69(5):743–58.
17.
DixonBJ, ReisC, HoWM, TangJ, ZhangJH. Neuroprotective strategies after neonatal hypoxic ischemic encephalopathy. Int J Mol Sci. 2015;16(9):22368–401.
18.
MassaroAN, JerominA, KadomN, VezinaG, HayesRL, WangKK, et al. Serum biomarkers of MRI brain injury in neonatal hypoxic ischaemic encephalopathy treated with whole-body hypothermia: A pilot study. Pediatr Crit Care Med. 2013;14(3):310–7.
19.
ChiangLM, ChenWY, YangYC, JengMJ. Elevation of serum S100 protein concentration as a marker of ischemic brain damage in extremely preterm infants. J Chin Med Assoc. 2015;78(10):610–6.
20.
DistefanoG, CurreriR, BettaP, IsajaMT, RomeoMG, AmatoM. Serial protein S-100 serum levels in preterm babies with perinatal asphyxia and periventricular white matter lesions. Am J Perinatol. 2002;19(6):317–22.
21.
PrakashR. Effect of postnatal magnesium therapy on neonatal seizure in infants with moderate to severe hypoxic ischemic encephalopathy: A post- hoc subgroup analysis. Int J Contemp Pediatr. 2016;3(4):1425–9.
22.
AhmedRFK, ShrikanthSN. Evaluation of safety of magnesium of sulphate therapy in neonates with birth asphyxia. Int J Contemp Pediatr. 2016;3(1):80–5.
23.
AnabreesJ. Magnesium sulphate for newborns with HIE; synopsis of evidence from a systematic review. J Clin Neonatol. 2013;2(3):114–6.
24.
ZaighamM, LundbergF, HayesR, UndénJ, OlofssonP. Umbilical cord blood concentrations of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) in neonates developing hypoxic-ischemic encephalopathy. J Matern Fetal Neonatal Med. 2016;29(11):1822–8.
25.
GazzoloD, PluchinottaF, BashirM, AboulgarH, SaidHM, ImanI, BAuthor, et al. Neurological abnormalities in full-term asphyxiated newborns and salivary S100B testing: The “cooperative multitask against brain injury of neonates” (CoMBINe) international study. PLoS One. 2015;10(1):e0115194.
26.
ZaighamM, LundbergF, OlofssonP. Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns. Early Human Development. 2017;112:48–53.
27.
MassaroAN, ChangT, KadomN, TsuchidaT, ScafidiJ, GlassP, et al. Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. J Pediatr. 2012;161(3):434–40.
28.
MassaroAN, ChangT, BaumgartS, McCarterR, NelsonKB, GlassP. Biomarkers S100B and NSE predict outcome in hypothermia-treated encephalopathic newborns. Pediatr Crit Care Med. 2014;15(7):615–22.
29.
SchulteS, PodlogLW, Hamson-UtleyJJ, StrathmannFG, StrüderHK. A systematic review of the biomarker S100B: Implications for sport-related concussion management. J Athl Train. 2014;49(6):830–50.
30.
GreenbergMB, PennAA, WhitakerKR, KogutEA, El-SayedYY, CaugheyAB, et al. Effect of magnesium sulfate exposure on term neonates. J Perinatol. 2013;33(3):188–93.
